GLP-1: The 360° view

Published on April 15, 2024

The GLP-1 agonist class of drugs, pioneered by Eli Lilly and Novo Nordisk, has become the biggest news story within the biopharma industry of the last couple of years. With tremendous clinical data supporting >20% weight loss and reduction in cardiovascular outcomes, there is seemingly no limit to the potential of these medicines. Analysts and […]

Continue reading on website
Other news

BioProcess International: Abzena scales up bioconjugation capacity with PA Expansion

April 11, 2024
Abzena has invested $5 million to expand its Bristol, Pennsylvania facility adding Sartorius’ Hipersep Flowdrive pilot system to enhance purificationAs a part of the expansion, the contract development and manufacturing organization (CDMO) has optimized the site’s Quality Control (QC) and analytical laboratory layouts and technologies and added five Waters Arc Premier LC Systems and two Acquity Pr

2024 Inspire Recovery Conference Insights

April 15, 2024
The second annual Inspire Recovery conference, held recently in Nashville, brought together representatives from various organizations nationwide, from managed care to state Medicaid agencies to the provider and social support communities. This full-day conference presented by Wayspring included specific panels addressing substance use disorder (SUD) treatment access, state and health plan collabo